13-year-old Michigan boy dies 3 days after Second Dose of Pfizer Vaccine, Aunt Says “Moral, Ethical, Health Question” Needs Answer


Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

A 13-year-old boy from Michigan died June 16, three days after he received his second dose of Pfizer’s COVID vaccine.

Preliminary autopsy results show that following his vaccination, Jacob Clynick’s heart was enlarged and surrounded by fluid – symptoms similar to those described in other young men who experienced myocarditis following COVID vaccination.

On June 20, Clynick’s aunt, Tami Burages, posted a tweet with a photo of his nephew’s vaccination card and this statement, although he has already deleted this tweet:

“A week ago today my brother’s 13 sons were shot in the 2nd covid. Less than 3 days later he died. The initial results of the autopsy (done on Friday) were that his heart had enlarged and there was fluid surrounding it. She had no known health problems. There is no cure. ”

The Burages also tweeted, which he also took:

“Our family was ruined. I struggled to put it on Twitter. I am pro-vaccine. We vaccinated my own 14 -year -old son as soon as it was available. I know it’s * mostly safe *.

“@CDCgov needs to investigate this. There have been other cases of myocarditis in young men who received their 2nd @pfizer shot. Did some die from it in the United States or my nephew the first?

“Should any innocent child be a lamb sacrificed at this event? There are questions about morals, ethics and health that need to be answered. If Jacob hadn’t received the 2nd shot, we believe he was alive today. ”

Tweet about Jacob

The death of the young reports at the Centers for Disease Control and Prevention (CDC) and is being investigated by federal health regulators to determine if there is a link between mortality and vaccination – according to the Saginaw County Health Department – which received notification from the Saginaw Medical Examiner’s office on the boy’s death.

“The loss of a young person’s life for any reason is sad,” the health department said. said in a statement. “Health officer Chris Harrington, MPH, and medical director Delicia Pruitt, MD, are mothers of children almost the age of the boy, so it’s almost coming to their home.”

As of Wednesday, the CDC’s Vaccine Adverse Event Reporting System (VAERS) does not include an entry for a Michigan teenager who died in June. Agreed to various reports, there was a two -month data delay between reports produced by VAERS and those published to the public.

FDA to add warning about heart inflammation in Pfizer and Moderna vaccines

During a Meeting on June 23, the CDC’s Advisory Committee on Immunization Practices (ACIP) says there is a “likely association” with “mild” heart inflammation in adolescents and young adults after vaccination.

Food and Drug Administration in the United States said it would add a warning of COVID vaccines made by Pfizer and Modern about rare cases of heart inflammation in adolescents and adults.

During the ACIP meeting on June 23, members recognized more than 1,200 cases of inflammation of the heart in 16- to 24-years-olds, which often occurs in men. However, they say the benefits of vaccines outweigh the risks.

Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, said in a presentation that data from one of the agency’s security monitoring systems – Vaccine Safety Datalink (VSD) – suggests a rate of 12.6 cases per million at 12- to 39-years-old while three weeks after the second shooting.

During the meeting public comment session, the commentators reprimanded the CDC and its advisory committee for claiming the benefits of experiment COVID vaccines are more at risk to adolescents, if adolescents have a lower risk of dying from COVID, and are at the lowest risk of being experienced. bad events.

Meryl Nass, a doctor of internal medicine, pointed out several errors in the data used in the ACIP presentation:

“As of now, there are two main ways to reduce the rate of myocarditis [during the presentation] are lump lump people from the age of 39 and below –– even if the highest price [of myocarditis] are in the youngest children. This water reduces the rate. The other method is to include only a very narrow window of time after vaccination is started in the 12-15 age group, thus eliminating most of the second doses, which is when the 75% or more of myocarditis cases Also, the genders are sometimes mixed. And rates for girls are lower than for boys. ”

During the presentations, Drs. Megan Wallance is the overall effectiveness of Pfizer’s COVID vaccine in the 12 to 15 age group 100% and Moderna’s are comparable. Wallace then performed a risk / benefit analysis comparing myocarditis cases versus hospitalization rates for COVID in people aged 12 and 29.

“The problem with his analysis is that now the used myocarditis rate is very low. But the danger comes COVID raised, ”Nass said.

Other public commentators blamed the CDC to withhold VAERS data and delay the publication of adverse incident reports. The actual numbers, one commentator estimated, are three to 14 times higher than what the public has done to date.

The doctor Dr. Leslie Moore said the current VAERS data is frightening and frightening:

“We only have the VAERS system, which is voluntary self-reporting. We know that VAERS only accounts for 1-10% of all adverse events. Adverse events are severely unreported for a variety of reasons. .I watched VAERS open this morning.These products have accumulated 6,000 deaths and 20,000 hospitalized in the U.S., alone –– more than the other 70 vaccines in the last 30 years combined. that’s severe under-reporting and a two-month backlog. Face it, these vaccines aren’t safe. “

the latest data from VAERS show 1,117 cases of myocarditis and pericarditis (inflammation of the heart) in all age groups reported in the U.S. following COVID vaccination between Dec.14, 2020 and June 11, 2021. Of the 1,117 cases reported, 686 cases dedicated to Pfizer, 391 cases in Moderna and 36 cases of the COVID vaccine at Johnson & Johnson.

Even if Shimabukuro, during the ACIP meeting on June 23, cited VSD data on the rate of heart inflammation in 12- to 39-year-olds, The Protector did not report VSD data related to adverse events with COVID vaccine, including heart inflammation. Because that’s unlike VAERS, VSD doesn’t make data collected through the system readily available to the public.

VSD is a collaborative project between the CDC and “multiple health plans,” according to it website. Even if the public cannot access VSD data, there is a process by which researchers can apply to access the data.

According to the VSD website:

“There is many ways Interested researchers can access VSD data. In 2002, VSD established a data sharing program on National Center for Health Statistics (NCHS) Research Data Center (RDC) allow external Analysts to Visit (1) behavior recent vaccine safety studies using VSD data files available to the CDC or (2) to settle also specific datasets studied from published VSD studies.

The VSD data sharing program is a three -step process:

  1. Submission of RDC proposals to CDC at NCHS
  2. Submission of proposals to VSD site Institutional Review Boards (IRBs)
  3. Use of the CDC’s RDC in NCHS





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *